[SyneuRx] Important resolutions of the 115 Annual General Meeting
SyneuRx held its Annual General Meeting on May 29, 115. The meeting approved the 114 fiscal year loss compensation plan and financial statements, and passed amendments to the Articles of Incorporation and the 'Procedures for Acquisition or Disposal of Assets'.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:23 (34h 23m after Collected)
1. Date of AGM: 115/05/29. 2. Resolution 1 (Loss compensation): Approved the 114 fiscal year loss compensation plan. 3. Resolution 2 (Articles of Incorporation): Passed the amendment to the Articles of Incorporation. 4. Resolution 3 (Business report and financial statements): Approved the 114 fiscal year business report and financial statements. 5. Resolution 4 (Director/Supervisor election): None. 6. Resolution 5 (Other): Passed the revision of the 'Procedures for Acquisition or Disposal of Assets'. 7. Other: None.
FAQ
What was passed at the SyneuRx shareholder meeting?
Amendments to the Articles of Incorporation and asset acquisition/disposal procedures were passed.